summaryrefslogtreecommitdiffstats
diff options
context:
space:
mode:
authorDavid A. Madore <david+git@madore.org>2020-04-22 00:58:07 +0200
committerDavid A. Madore <david+git@madore.org>2020-04-22 00:58:07 +0200
commit4dc558b4310eaee625a09f4cacaa7f639c108a20 (patch)
tree474b93450bddd6649fa353c122666ae7f150e9dd
parentd96b18ca65e96abc64cffa55f30f58aa8c376e24 (diff)
downloadcovid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.tar.gz
covid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.tar.bz2
covid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.zip
Summary of the state of knowledge on immunity.
-rw-r--r--covid19-links.md4
1 files changed, 4 insertions, 0 deletions
diff --git a/covid19-links.md b/covid19-links.md
index 7cc89ad..a54519a 100644
--- a/covid19-links.md
+++ b/covid19-links.md
@@ -83,6 +83,10 @@
5.7% of the population will have been infected by May 11. *\[Move
this to the country-specific section?\]*
+* [Persistence and efficiency of antibodies against SARS-CoV-2: the
+ state of current
+ knowledge](https://www.vidal.fr/actualites/24770/persistance_et_efficacite_des_anticorps_neutralisants_contre_le_sars_cov_2_etat_des_connaissances_et_lecons_des_autres_coronavirus_humains/) (2020-04-20 \[in French\]).
+
* [Effectiveness of convalescent plasma therapy in severe COVID-19
patients](https://www.pnas.org/content/early/2020/04/02/2004168117)
(2020-04-06, PNAS) ⚔ [Twitter thread discussing